[Peroxisome proliferators and hepatocarcinogenesis].
Tamura
H
H
Department of Clinical Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Science.
D002455:Cell Division / Q000187:drug effects; D002994:Clofibrate / Q000009:adverse effects*; D006801:Humans; D008099:Liver / Q000166:cytology; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008830:Microbodies / Q000187:drug effects*; D018384:Oxidative Stress; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors
D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D002994:Clofibrate